Wordt geladen...
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors
Tyrosine kinase inhibitors (TKIs) can cause cardiotoxicity, and some suggest routine monitoring of cardiac function during TKI use. We describe two cases of TKI‐induced heart failure (HF) that suggest the utility of monitoring with laboratory tests is questionable. One patient developed HF 5 days af...
Bewaard in:
| Gepubliceerd in: | Oncologist |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656470/ https://ncbi.nlm.nih.gov/pubmed/30971480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0891 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|